EUVIMEDEUVIMED entdecken
Crossref

A Update on Early Detection and Management of Diabetes: Comparison of Fasting Serum Glucagon among Diabetics and Non-Diabetics

Mirza Zeeshan Sikandar, Fuad Shafiq, Naveed Shahzad Ahmad, Suman Rafaqat, Waqar Ali, Faheem Usman Sulehri

International Journal of Diabetes Management · 2023

DOI: 10.61797/ijdm.v2i1.245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Diabetes Management, 2023. Verfasst von Mirza Zeeshan Sikandar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes is a well- known disease that is spreading globally and causing many other complications like nephropathy, eye disorders, foot disease and other heart related diseases. It also has a high mortality rate. Glucagon is the principal hyperglycemic hormone, and acts as a counterbalancing hormone to insulin. Its level increases in early stages of diabetes, however with the progression of disease it gradually decreases in diabetic patients.

Aim

The aim of this study was to compare the glucagon levels in diabetics and non-diabetics. Materials and Methods: This was a cross-sectional study in which the data and blood samples of diabetics and non-diabetics with or without family history of diabetes were collected during December 2022 to May 2023. Then by SDS Page analysis glucagon levels were estimated in the blood samples of participants and results were analyzed by SPSS statistical version 25.0.

Results

In Group A, 25 (83.33%) had high levels of fasting serum glucagon while in group B only 18 (60%) had raised serum glucagon levels with the p value of 0.001. High glucagon level was observed in non-diabetics with family history of diabetes, as maximum number of participants 60% (n=18) with high level glucagon fall in this group. The p value is 0.001 shows the association between glucagon and family history of nondiabetic is significant.

Conclusion

Fasting serum glucagon could be an early sign of insulin resistance in non-diabetics and diabetics. Therefore, in clinical management of glucagon level must be accounted and managed accordingly.

Zitieren

APA

Sikandar, M. Z., Shafiq, F., Ahmad, N. S., Rafaqat, S., Ali, W., & Sulehri, F. U. (2023). A Update on Early Detection and Management of Diabetes: Comparison of Fasting Serum Glucagon among Diabetics and Non-Diabetics. International Journal of Diabetes Management. https://doi.org/10.61797/ijdm.v2i1.245

Vancouver

Sikandar MZ, Shafiq F, Ahmad NS, Rafaqat S, Ali W, Sulehri FU. A Update on Early Detection and Management of Diabetes: Comparison of Fasting Serum Glucagon among Diabetics and Non-Diabetics. International Journal of Diabetes Management. 2023. doi:10.61797/ijdm.v2i1.245

BibTeX
@article{Sikandar2023,
  author = {Sikandar, Mirza Zeeshan and Shafiq, Fuad and Ahmad, Naveed Shahzad and Rafaqat, Suman and Ali, Waqar and Sulehri, Faheem Usman},
  title = {A Update on Early Detection and Management of Diabetes: Comparison of Fasting Serum Glucagon among Diabetics and Non-Diabetics},
  journal = {International Journal of Diabetes Management},
  year = {2023},
  doi = {10.61797/ijdm.v2i1.245}
}
Kostenlos starten →